Nanion 运营日志


02.06.2020: 新发表论文预览 - 内溶酶体离子通道有可能成为新冠病毒的致命弱点吗?

内溶酶体离子通道有可能成为 SARS-CoV2 (新型冠状病毒)的致命弱点吗?


The ongoing SARS-CoV2 outbreak has developed into a global pandemic. Despite previous outbreaks of SARS-CoV and the related MERS-CoV in recent years, neither a vaccine nor any other medication for an effective treatment are currently available. Endo-lysosomal two-pore cation channels have now emerged as potential novel targets for SARS-CoV treatment.

Download the Publication



Click here for a detailed look and references, inclusive of our latest application notes available for download - dealing with P2X3 and Chronic Cough


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.